What are the symptoms of malignant lymphoma and how to treat it

Lymphoma is a very difficult cancer to treat, and symptoms may be present all over the body. Since lymph nodes are located in different parts of the body, do you know the symptoms of lymphoma? How is it treated?

The clinical features are painless, progressive lymphoid tissue hyperplasia, especially of superficial lymph nodes, often accompanied by splenomegaly, anemia, fever, and advanced malignant disease. Although malignant lymphoma is relatively rare in my country, new cases have increased year by year in recent years, and its incidence and mortality rate rank first among all malignant tumors 11-13. This disease can occur at any age, but most patients are young, more male than female, and higher in urban areas than in rural areas.

For patients with lymphoma, relevant doctors should choose different treatment plans according to the patient's physical condition, pathological type and clinical stage to achieve the purpose of cure. The importance of the first treatment is particularly emphasized here. If the treatment is not appropriate, future continued treatment will be particularly difficult and the efficacy will be reduced. Therefore, once diagnosed with lymphoma. It is best to find a general specialist for treatment, which is also the key to cure. Commonly used treatment methods are:

1. Combination chemotherapy: Most lymphomas require combination chemotherapy. Common regimens are MOPP nitrogen mustard, vincristine, methylpyrene, sedation ABVD doxorubicin, bleomycin, vinblastine, azathiocarbamide, CHOP cyclophosphamide, doxorubicin, vincristine, sedation BACOP bleomycin, doxorubicin, cyclophosphamide, vincristine, sedation, and some require high-dose methotrexate, cytarabine, and podophyllotoxin.

2. Radiotherapy: CO-60 or accelerator is commonly used, with a dose of 40-60Gy/4-6 weeks, depending on the condition.

3. Immunotherapy: After radiotherapy and chemotherapy for some lymphomas, interferon treatment can improve the cure rate.

4. Rituximab is effective against monoclonal antibody CD20-positive B-cell malignant lymphoma.